Dr. Peter Hedera, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Years since graduation
- 39
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 224
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
KY license 53689 · TN license MD36171 -
Neurological Surgery Physician
TN license MD36171
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Norton Hospitals, Inc Louisville, KY
- Uofl Health - Jewish Hospital and Mary & Elizabeth Hospital Louisville, KY
- University of Louisville Hospital Louisville, KY
Medical groups
- University of Louisville Physicians Inc (1,445 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 224
- Services billed
- 536
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 104 | 69 |
| Established patient office or other outpatient visit, 30-39 minutes | 96 | 64 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 36 | 20 |
| New patient office or other outpatient visit, 45-59 minutes | 27 | 27 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 26 | 12 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 23 | 13 |
| Established patient office or other outpatient visit, 40-54 minutes | 23 | 17 |
| New patient office or other outpatient visit, 30-44 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Louisville, KY | 272 |
| Carbidopa-Levodopa Er (carbidopa/levodopa) Other prescribers in Louisville, KY | 170 |
| Donepezil Hcl Other prescribers in Louisville, KY | 136 |
| Clonazepam Other prescribers in Louisville, KY | 118 |
| Nuplazid (pimavanserin tartrate) | 101 |
| Gabapentin Other prescribers in Louisville, KY | 99 |
| Primidone Other prescribers in Louisville, KY | 98 |
| Topiramate Other prescribers in Louisville, KY | 83 |
| Amantadine (amantadine hcl) Other prescribers in Louisville, KY | 65 |
| Quetiapine Fumarate Other prescribers in Louisville, KY | 64 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 67 payments worth $39,608 in total to this clinician.
| Neurocrine Biosciences, Inc. | $25,626 |
|---|---|
| Mdd US Operations, LLC | $7,613 |
| Bayer HealthCare Pharmaceuticals Inc. | $1,848 |
| Orphalan Inc | $1,800 |
| Abbott Laboratories | $1,711 |
| Vertex Pharmaceuticals Incorporated | $975 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.32 |
| Supernus Pharmaceuticals, Inc. | $12.10 |
| Compensation for services other than consulting (speaking, faculty) | $12,900 |
|---|---|
| Consulting Fee | $11,775 |
| Honoraria | $8,050 |
| Travel and Lodging | $4,785 |
| Food and Beverage | $2,098 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Neurocrine Biosciences, Inc. Apr 3, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $10,800 |
| Neurocrine Biosciences, Inc. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $5,700 |
| Neurocrine Biosciences, Inc. Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $4,800 |
| Mdd US Operations, LLC Oct 2, 2025 | Honoraria | $4,250 |
| Neurocrine Biosciences, Inc. Mar 10, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $2,400 |
| Mdd US Operations, LLC Aug 13, 2025 | Honoraria | $2,000 |
| Orphalan Inc Oct 7, 2025 | Honoraria CUVRIOR · Hepatology | $1,800 |
| Abbott Laboratories Feb 28, 2025 | Travel and Lodging INFINITY · Structural Heart · travel to Minnetonka, MN · in-kind | $774 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 13, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $595 |
| Neurocrine Biosciences, Inc. Mar 9, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $555 |
All 35 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Neurocrine Biosciences, Inc. Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $4,800 |
| Orphalan Inc Oct 7, 2025 | Honoraria CUVRIOR · Hepatology | $1,800 |
| Mdd US Operations, LLC Oct 7, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $70.74 |
| Mdd US Operations, LLC Oct 7, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $36.00 |
| Mdd US Operations, LLC Oct 7, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $14.00 |
| Mdd US Operations, LLC Oct 2, 2025 | Honoraria | $4,250 |
| Vertex Pharmaceuticals Incorporated Sep 19, 2025 | Consulting Fee | $508 |
| Mdd US Operations, LLC Sep 12, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $20.51 |
| Mdd US Operations, LLC Sep 10, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $398 |
| Mdd US Operations, LLC Aug 13, 2025 | Honoraria | $2,000 |
| Mdd US Operations, LLC Aug 11, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $368 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 13, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $595 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 13, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $78.28 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 13, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $52.32 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 12, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $406 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 12, 2025 | Travel and Lodging travel to Boston, MA · in-kind | $262 |
| Neurocrine Biosciences, Inc. Apr 3, 2025 | Consulting Fee INGREZZA · Neuropsychiatry | $10,800 |
| Abbott Laboratories Mar 14, 2025 | Travel and Lodging INFINITY · Structural Heart · travel to Austin, TX · in-kind | $280 |
| Neurocrine Biosciences, Inc. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $5,700 |
| Vertex Pharmaceuticals Incorporated Mar 11, 2025 | Consulting Fee | $467 |
| Neurocrine Biosciences, Inc. Mar 10, 2025 | Compensation for services other than consulting (speaking, faculty) INGREZZA · Neuropsychiatry | $2,400 |
| Neurocrine Biosciences, Inc. Mar 9, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $555 |
| Neurocrine Biosciences, Inc. Mar 9, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $44.00 |
| Neurocrine Biosciences, Inc. Mar 8, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $243 |
| Neurocrine Biosciences, Inc. Mar 8, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $61.72 |
| Neurocrine Biosciences, Inc. Mar 8, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $45.50 |
| Neurocrine Biosciences, Inc. Mar 7, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $179 |
| Neurocrine Biosciences, Inc. Mar 7, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $24.63 |
| Neurocrine Biosciences, Inc. Mar 7, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $19.80 |
| Neurocrine Biosciences, Inc. Mar 7, 2025 | Travel and Lodging INGREZZA · Neuropsychiatry · travel to San Diego, CA · in-kind | $14.00 |
| Abbott Laboratories Feb 28, 2025 | Travel and Lodging INFINITY · Structural Heart · travel to Minnetonka, MN · in-kind | $774 |
| Abbott Laboratories Feb 28, 2025 | Travel and Lodging INFINITY · Structural Heart · travel to Austin, TX · in-kind | $92.54 |
| Abbott Laboratories Feb 28, 2025 | Travel and Lodging INFINITY · Structural Heart · travel to Austin, TX · in-kind | $91.18 |
| Abbott Laboratories Feb 28, 2025 | Travel and Lodging INFINITY · Structural Heart · travel to Austin, TX · in-kind | $51.10 |
| Abbott Laboratories Feb 28, 2025 | Travel and Lodging INFINITY · Structural Heart · travel to Austin, TX · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $23,396 in research payments for these studies, mostly to the institutions running them.
- A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
Ipsen Pharma Sas · Completed · NCT04936542 - A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease
UCB SA · Completed · NCT06055985
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.